BiOptix Announces Partnership with XTAL Biostructures
News Sep 24, 2015

BiOptix has announced that XTAL BioStructures Inc., a pharmaceutical and biotechnology industries service provider, is adding the BiOptix 404pi to its suite of biophysical tools.
XTAL BioStructures is a contract research organization that provides drug discovery and intellectual property development services to the pharmaceutical and biotechnology industries, including high quality protein production, biophysical characterization, X-ray crystallography and with a focus on affinity-based screening techniques.
“This partnership will further XTAL’s dedication to providing high quality research services through the availability of the BiOptix Enhanced Surface Plasmon Resonance (eSPR) technology, an advanced and highly sensitive optical technology,” said Robert K. Suto, Ph.D., president and CSO of XTAL BioStructures.
XTAL is now able to offer customers access to BiOptix’s patented enhanced surface plasmon resonance (e-SPR) technology, which delivers high sensitivity (100 Da) and higher throughput by combining proprietary technology with an advanced, multi-injector fluidics system.
“With the addition of the BiOptix 404pi label-free system to their existing suite of biophysical tools, both companies can now work together to assist those customers who need both biophysical assessment and real-time, label-free interaction analysis to move their drug discovery projects forward,” said Rick Whitcomb, president and CEO of BiOptix.
RELATED ARTICLES
170 Potential Lung Cancer Drug Targets Identified Using Unique Cellular Library
NewsAfter testing more than 200,000 chemical compounds, UT Southwestern’s Simmons Cancer Center researchers have identified 170 chemicals that are potential candidates for development into drug therapies for lung cancer.
READ MOREPrimary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening
NewsA multidisciplinary team of scientists share recent advancements in innovative in-vitro cancer biology methods for screening drug-like molecules in cancer tissue relevant models in a new report published online ahead-of-print at SLAS Discovery.
READ MOREMaking Drugs ‘Smarter’ Using Nanotechnology
NewsA new method has been developed to make drugs ‘smarter’ using nanotechnology so they will be more effective at reaching their target.
READ MOREComments | 0 ADD COMMENT
Like what you just read? You can find similar content on the communities below.
Drug DiscoveryTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREEInternational Conference on Analytical and Bio Analytical Techniques
Oct 31 - Nov 01, 2018
Login
You must be logged in to post a comment.